Drugs / LY03004
last change Jan 2015 re-read 2 minutes ago

LY03004

Developed for
schizoaffective disorder · schizophrenia
Investigated by
Luye Pharma Group Ltd.

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02091388 Sep 2014 → Jan 2015 schizoaffective disorder, schizophrenia Luye Pharma Group Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LY03004 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02091388